Lymphocyte Engineering Conference, Madrid 2018

Keynote Speakers

malcolm brenner
center for cell and gene therapy, texas children`s hospital
Usa
Carl June
perelman School of medicine, university of pennsylvania
usa
zelig eshhar
the weizmann institute of science and sourasky medical center
usa

WELCOME TO THE INTERNATIONAL CONFERENCE
ON LYMPHOCYTE ENGINEERING

The International Conference on Lymphocyte Engineering (ICLE 2018) will provide a dedicated platform to advance research, clinical translation and treatment in immuno-gene therapy. ICLE brings together immunotherapy with cell and gene therapy to foster interdisciplinary collaborations, deepening the connection between basic and clinical research across related disease specialties: oncology, pathogenic diseases, autoimmunity, immunodeficiencies and others.

 With unprecedented success from more than 200 clinical trials, the recent increase in investment funding, and FDA approvals of CAR-T therapies, lymphocyte engineering has a potentially significant role in the future of healthcare. Whether you are a scientist, clinical researcher, part of a start-up or an established industry company, ICLE 2018 will be your opportunity to network and discuss immuno-gene therapy with those as excited and passionate about the future as you.

 Join us in Madrid, 13-15 September 2018!

Leaders & Speakers



STAY UP-TO-DATE
Subscribe to our newsletter to get all the updates on the Conference

Keep Me Updated




CONNECT WITH US

#ICLE2018


   



sponsorship opportunities